Furthermore, we found that CEMIP activated CDC42/MAPK pathway-regulated EMT by enhancing the degradation of GRAF1, which was indispensable to CEMIP-mediated migration and invasion of CRC cells. The gene discussed is CEMIP; the disease is colorectal carcinoma.